OBJECTIVES: For the proper diagnosis of toxoplasmosis it is essential to determine the stage of the infection, for which the most preferred method is IgG avidity test. The avidity index (AI) should initially be low (AI≤0.3) in the acute phase and increase during the infection. However, persistent low avidity can occur in patients with latent toxoplasmosis, which can complicate the interpretation of the results. The aim of the study is to explain the causes of this phenomenon. METHODOLOGY: A retrospective study was carried out with 717 serum samples collected from 442 patients from the categories of pregnant and non-pregnant women, men, and newborns + infants (age < 0.5 year). The trends of AI kinetics were evaluated in repeatedly examined patients. The frequency of cases with low avidity was compared in individual categories of patients and in groups of people with acute and non-acute toxoplasmosis. RESULTS: The proportion of patients with initially low avidity was 42.1% in the acute toxoplasmosis group while it was 13.0% in the non-acute groups. In uninfected newborns with anti-Toxoplasma antibodies transmitted from the mother, a decrease in IgG avidity levels over time was observed, resulting in 29.2% of samples showing low (improper) avidity. While the dynamics of IgG avidity and the frequency of cases of improperly low avidity were similar in men and pregnant and non-pregnant women, the category of newborns and infants differed substantially for these indicators. CONCLUSIONS: Due to acceptable specificity and negative predictive value, high avidity can rule out acute toxoplasmosis, but moderate sensitivity complicates the possibility of its confirmation. The results of the avidity test must be interpreted in the context of the results of other methods.

National Institute of Public Health Unit of Biostatistics Prague Czech Republic

National Reference Laboratory for Toxoplasmosis National Institute of Public Health Prague Czech Republic

See more in PubMed

Krahenbuhl JL, Remington JS. The immunology of toxoplasma and toxoplasmosis. In Immunology of parasitic infections, 2nd ed.; Cohen S, Warren S Eds. Blackwell Scientific Publications: Oxford, United Kingdom, 1982; pp. 356–421.

Darcy F, Santoro F. Toxoplasmosis. In Parasitic infections and the immune system, Kierszenbaum F Ed. Academic Press: San Diego, U.S.A., 1990; pp. 163–201.

Jacquemard F. Clinical aspects of infection during pregnancy. In Congenital toxoplasmosis: Scientific background, clinical management and control, Ambroise TP, Petersen E Eds. Springer Verlag: Paris, France, 2000; pp. 111–120.

Gross U, Pelloux H. Diagnosis in the pregnant woman. In: Ambroise-Thomas P, Petersen E (Eds): Congenital toxoplasmosis. Scientific Background, Clinical Management and Control. Springer Verlag France, Berlin, Heidelberg, 2000; pp. 121–130

Hedman K, Lappalainen M, Seppäiä I, Mäkelä O. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis. 1989. Apr; 159(4):736–40. doi: 10.1093/infdis/159.4.736 . PubMed DOI

Hedman K, Lappalainen M, Söderlund M, Hedman L. Avidity of IgG in serodiagnosis of infectious diseases. Rev. Med. Microbiol. 1993; 4, 123–129.

Hazell SL. Clinical utility of avidity assays. Expert Opin Med Diagn. 2007; 1(4):511–9. doi: 10.1517/17530059.1.4.511 . PubMed DOI

Teimouri A, Mohtasebi S, Kazemirad E, Keshavarz H. Role of Toxoplasma gondii IgG avidity testing in discriminating between acute and chronic toxoplasmosis in pregnancy. J Clin Microbiol. 2020; 58(9):e00505–20. doi: 10.1128/JCM.00505-20 ; PMCID: PMC7448626. PubMed DOI PMC

Jenum PA, Stray-Pedersen B, Gundersen AG. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol. 1997; 35(8):1972–7. doi: 10.1128/jcm.35.8.1972-1977.1997 ; PMCID: PMC229886. PubMed DOI PMC

Barros GB, Lemos EM, E Silva-Dos-Santos PP, Dietze R, Zandonade E, Mineo JR, de Oliveira Silva DA, Pajuaba ACM, de Souza Gomes M, do Amaral LR, Coelho-Dos-Reis JG, Martins-Filho OA, Serufo JC. Proposed panel of diagnostic tools for accurate temporal classification of symptomatic T. gondii infection. J Immunol Methods. 2017; 451:61–70. doi: 10.1016/j.jim.2017.08.010 Epub 2017 Sep 4. . PubMed DOI

Lefevre-Pettazzoni M, Le Cam S, Wallon M, Peyron F. Delayed maturation of immunoglobulin G avidity: implication for the diagnosis of toxoplasmosis in pregnant women. Eur J Clin Microbiol Infect Dis. 2006; 25(11):687–93. doi: 10.1007/s10096-006-0204-1 . PubMed DOI

Alvarado-Esquivel C, Niewiadomski A, Schweickert B, Liesenfeld O. Antiparasitic treatment suppresses production and avidity of Toxoplasma gondii-specific antibodies in a murine model of acute infection. Eur J Microbiol Immunol (Bp). 2011; 1(3):249–55. doi: 10.1556/EuJMI.1.2011.3.9 Epub 2011 Sep 9. ; PMCID: PMC3906621. PubMed DOI PMC

Pokorný J, Čuřík B, Zástěra M. A tween-ether preparation of Toxoplasma gondii antigen for the complement fixation test. Bull. World Health Organ. 1972; 46(1):127–130. PubMed PMC

Zástěra M, Pokorný J, Jíra J, Valkoun A. Doplněk standardních metodik laboratorní diagnostiky toxoplasmózy. [Amendment to standard laboratory methods for diagnosing toxoplasmosis—in Czech]. Acta Hyg. Epidemiol. Microbiol. 1987; suppl. 3, 3–14.

Ondriska F, Čatár G, Vozarová G. The significance of complement fixation test in clinical diagnosis of toxoplasmosis. Bratisl. Lek. Listy. 2003; 104(6):189–196. PubMed

Sensini A, Pascoli S, Marchetti D, Castronari R, Marangi M, Sbaraglia G, Cimmino C, Favero A, Castelletto M, Mottola A. IgG avidity in the serodiagnosis of acute Toxoplasma gondii infection: a multicenter study. Clin Microbiol Infect. 1996; 2(1):25–29. doi: 10.1111/j.1469-0691.1996.tb00196.x . PubMed DOI

Findal G, Stray-Pedersen B, Holter EK, Berge T, Jenum PA. Persistent Low Toxoplasma IgG Avidity Is Common in Pregnancy: Experience from Antenatal Testing in Norway. PLoS One. 2015; 10(12):e0145519. doi: 10.1371/journal.pone.0145519 ; PMCID: PMC4703128. PubMed DOI PMC

Buffolano W, Lappalainen M, Hedman L, Ciccimarra F, Del Pezzo M, Rescaldani R, Gargano N, Hedman K. Delayed maturation of IgG avidity in congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis. 2004; 23(11):825–30. doi: 10.1007/s10096-004-1226-1 Epub 2004 Oct 19. . PubMed DOI

Caro-Garzón JD, Gómez-Henck C, Jaramillo-Giraldo T, Cifuentes-Botero JM, Gómez-Marín JE. Evaluation of the avidity test for the follow up on children treated for congenital toxoplasmosis during the first year of life. Itreia. 2021; 34(1):25–32. doi: 10.17533/udea.iatreia.70 DOI

Souza JY, Gomes TC, Rezende HHA, Storchilo HR, Rodrigues PG, Castro AM. IgG avidity in samples collected on filter paper: Importance of the early diagnosis of congenital toxoplasmosis. Rev Bras Ginecol Obstet. 2021; 43(12):887–893. English. doi: 10.1055/s-0041-1740272 Epub 2021 Dec 21. . PubMed DOI PMC

Fonseca ZC, Rodrigues IMX, Melo NCE, Avelar JB, Castro AM, Avelino MM. IgG avidity test in congenital toxoplasmosis diagnoses in newborns. Pathogens. 2017. 18; 6(2):26. doi: 10.3390/pathogens6020026 ; PMCID: PMC5488660. PubMed DOI PMC

Meroni V, Genco F, Tinelli C, Lanzarini P, Bollani L, Stronati M, Petersen E. Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T. gondii-specific immunoglobulin G antibodies. Clin Vaccine Immunol. 2009; 16(10):1517–20. doi: 10.1128/CVI.00253-09 Epub 2009 Aug 19. PubMed DOI PMC

Lefevre-Pettazzoni M, Bissery A, Wallon M, Cozon G, Peyron F, Rabilloud M. Impact of spiramycin treatment and gestational age on maturation of Toxoplasma gondii immunoglobulin G avidity in pregnant women. Clin Vaccine Immunol. 2007; 14(3):239–43. doi: 10.1128/CVI.00311-06 Epub 2007 Jan 3. ; PMCID: PMC1828858. PubMed DOI PMC

Ho-Yen DO. Clinical features. In Toxoplasmosis Human, Ho-Yen DO, Joss AWL Eds. Oxford University Press: Oxford, United Kingdom, 1992; pp. 56–78.

Remington JS, McLeod R, Desmonts G. Toxoplasmosis. In Infectious diseases of the foetus and newborn infant, 4th ed. Klein JO, Remington JS Eds, W.B. Saunders: Philadelphia, U.S.A. 1995; pp. 140–267.

Neves ES, Espíndola OM, Curi A, Amendoeira MR, Rocha DN, Gomes LHF, Guida LC. PCR-based diagnosis is not always useful in the acute acquired toxoplasmosis in immunocompetent individuals. Parasitol Res. 2021; 120(2):763–767. doi: 10.1007/s00436-020-07022-6 Epub 2021 Jan 8. . PubMed DOI

Čermáková Z, Prášil P, Valenta Z, Förstl M, Plíšková L, Bolehovská R. Zamyšlení nad "postavením" metody PCR v rutinní diagnostice toxoplazmózy při vyšetření periferní krve u imunokompetentních nemocných. [Considering the role of the PCR method in routine diagnosis of toxoplasmosis in peripheral blood tests in immunocompetent patients—in Czech]. Klin. Mikrobiol. Infekc. Lek. 2009; 15, 138–142. PubMed

Boquel F, Monpierre L, Imbert S, Touafek F, Courtin R, Piarroux R, Paris L. Interpretation of very low avidity indices acquired with the Liaison XL Toxo IgG avidity assay in dating toxoplasmosis infection. Eur J Clin Microbiol Infect Dis. 2019; 38(2):253–257. doi: 10.1007/s10096-018-3421-5 Epub 2018. Nov 8. . PubMed DOI

Alexander J, Roberts CW, Walker W, Reichmann G, Hunter CA. The immunology of Toxoplasma gondii infection in the immune competent host. In Congenital toxoplasmosis: Scientific background, clinical management and control, Ambroise-Thomas P, Petersen E, Eds. Springer Verlag: Paris, France, 2000; pp. 69–82.

Kodym P, Machala L, Rohácová H, Sirocká B, Malý M. Evaluation of a commercial IgE ELISA in comparison with IgA and IgM ELISAs, IgG avidity assay and complement fixation for the diagnosis of acute toxoplasmosis. Clin Microbiol Infect. 2007; 13(1):40–7. doi: 10.1111/j.1469-0691.2006.01564.x . PubMed DOI

Siddiqui N, Shujatullah F, Khan HM, Rabbani T, Khan PA. IgG avidity antibodies against Toxoplasma gondii in high risk females of reproductive age group in India. Korean J Parasitol. 2014; 52(5):487–91. doi: 10.3347/kjp.2014.52.5.487 Epub 2014 Oct 22. ; PMCID: PMC4210730. PubMed DOI PMC

Abolghasem SP, Bonyadi MR, Babaloo Z, Porhasan A, Nagili B, Gardashkhani OA, Salehi P, Hashemi M, Varshoghi M, Gaffari GO. IgG avidity test for the diagnosis of acute Toxoplasma gondii infection in early pregnancy. Iran J Immunol. 2011; 8(4):251–5. . PubMed

Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS. Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis. 200; 183(8):1248–53. doi: 10.1086/319672 Epub 2001 Mar 16. . PubMed DOI

Dard C, Fricker-Hidalgo H, Brenier-Pinchart MP, Pelloux H. Relevance of and new developments in serology for Toxoplasmosis. Trends Parasitol. 2016; 32(6):492–506. doi: 10.1016/j.pt.2016.04.001 Epub 2016 May 7. . PubMed DOI

Petersen E, Borobio MV, Guy E, Liesenfeld O, Meroni V, Naessens A, Spranzi E, Thulliez P. European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index. J Clin Microbiol. 2005; 43(4):1570–4. doi: 10.1128/JCM.43.4.1570-1574.2005 ; PMCID: PMC1081322. PubMed DOI PMC

Flori P, Tardy L, Patural H, Bellete B, Varlet MN, Hafid J, Raberin H, Sung RT. Reliability of immunoglobulin G antitoxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant women. Clin Diagn Lab Immunol. 2004; 11(4):669–74. doi: 10.1128/CDLI.11.4.669-674.2004 ; PMCID: PMC440619. PubMed DOI PMC

Bobić B, Klun I, Vujanić M, Nikolić A, Ivović V, Živković T, Djurković-Djaković O. Comparative evaluation of three commercial Toxoplasma-specific IgG antibody avidity tests and significance in different clinical settings. J Med Microbiol. 2009; 58(Pt 3):358–364. doi: 10.1099/jmm.0.006668-0 . PubMed DOI

Bonyadi MR, Bastani P. Modification and evaluation of avidity IgG testing for differentiating of Toxoplasma gondii infection in early stage of pregnancy. Cell J. 2013; 15(3):238–43. Epub 2013 Aug 24. ; PMCID: PMC3769606. PubMed PMC

Murat JB, Dard C, Fricker Hidalgo H, Dardé ML, Brenier-Pinchart MP, Pelloux H. Comparison of the Vidas system and two recent fully automated assays for diagnosis and follow-up of toxoplasmosis in pregnant women and newborns. Clin Vaccine Immunol. 2013; 20(8):1203–12. doi: 10.1128/CVI.00089-13 Epub 2013 Jun 5. ; PMCID: PMC3754515. PubMed DOI PMC

Tanimura K, Nishikawa A, Tairaku S, Shinozaki N, Deguchi M, Morizane M, Ebina Y, Morioka I, Yamada H. The IgG avidity value for the prediction of Toxoplasma gondii infection in the amniotic fluid. J Infect Chemother. 2015; 21(9):668–71. doi: 10.1016/j.jiac.2015.05.013 Epub 2015 Jun 9. . PubMed DOI

Emelia O, Rahana AR, Mohamad Firdaus A, Cheng HS, Nursyairah MS, Fatinah AS, Azmawati MN, Siti NA, Aisah MY. IgG avidity assay: a tool for excluding acute toxoplasmosis in prolonged IgM titer sera from pregnant women. Trop Biomed. 2014. Dec; 31(4):633–40. . PubMed

Roberts A, Hedman K, Luyasu V, Zufferey J, Bessières MH, Blatz RM, Candolfi E, Decoster A, Enders G, Gross U, Guy E, Hayde M, Ho-Yen D, Johnson J, Lécolier B, Naessens A, Pelloux H, Thulliez P, Petersen E. Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis. 2001; 20(7):467–74. doi: 10.1007/pl00011289 . PubMed DOI

Montoya JG, Huffman HB, Remington JS. Evaluation of the immunoglobulin G avidity test for diagnosis of toxoplasmic lymphadenopathy. J Clin Microbiol. 2004; 42(10):4627–31. doi: 10.1128/JCM.42.10.4627-4631.2004 ; PMCID: PMC522337. PubMed DOI PMC